Abstract:The aim of this work is to review the published studies on radiation resistance mechanisms and molecular markers involved in different tumors. The revision has been focused in the last 5 years (2016–2021).Radioresistance is a cause of concern as it causes failure of radiation therapy and subsequent tumor relapse. Combination chemotherapy and radiation therapy are clinically successful in treating many types of tumors. Despite continued improvements in cancer treatment, locoregional recurrence or metastatic spread continues to occur in a high proportion of patients after being treated with radiation therapy or combination treatments. There is strong evidence that cancer stem cells contribute to radiation resistance, contributing to treatment failure. The mechanisms of radiation resistance in different tumors are not fully understood. A better understanding of cancer stem cells and the associated signaling pathways that regulate radiation resistance will open up new strategies for treating cancer by radiation therapy. Radiation can damage malignant cells mainly by the induction of DNA double-strand breaks. However, in some tumors appear resistant cells that repopulate the tumor following therapy leading over time to the failure of the treatment. Native mechanisms and induced pathways are the cause of radiation resistance. It has been described that numerous molecular markers acting through numerous mechanisms of action involved in radiation resistance, such as apoptosis resistance, alterations of cell growth, proliferation and DNA repair, hypoxia, increase in invasiveness and migration capacity, cell cycle alterations, and expression of heat shock proteins, among others. Therefore, resistance to radiation is a multifactorial phenomenon that, in different cell types, occurs through different regulatory mechanisms in which different molecules intervene. Resistance can be acquired by altering different regulatory pathways in different tumors. The knowledge of radiation resistance markers could help in the classification and treatment of patients with more aggressive tumors.

Advances of study in affecting factors of tumor radiosensitivity

Research progress on factors affecting the sensitivity of breast cancer to radiotherapy: a narrative review

Molecular mechanisms of sensitivity and resistance to radiotherapy

Myriad factors and pathways influencing tumor radiotherapy resistance

Research development of the correlative genes in cancer radiosensitization

Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity

Recent advances in radiotherapy and radiotherapy sensitization

Highlights on molecular targets for radiosensitization of breast cancer cells: Current research status and prospects

Research Advances in Radiotherapy Combined with Immunotherapy for Cancer

Factors and molecular mechanisms of radiation resistance in cancer cells

Research progress on the bystander effect of radiotherapy in vivo

Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment

Deciphering the Biological Effects of Radiotherapy in Cancer Cells

Research Progress in the Mechanism of Molecular Targeted Anti-tumor Drugs

Research progress on nano-sensitizers for enhancing the effects of radiotherapy

Research Progress of Radiosensitization Effects of High-Z Metallic Materials in Tumor Radiotherapy

Analysis of Radio-Sensitization Patents in China from 2006 to 2015

Mechanism and clinical value of exosomes and exosomal contents in regulating solid tumor radiosensitivity

Radiotherapy modulates tumor cell fate decisions: a review

Application of nanomedicine in radiotherapy sensitization

Enhancement of Radiosensitization by Metal-Based Nanoparticles in Cancer Radiation Therapy